In Vitro Assays for the Assessment of Safety and Toxicity in Pharmacopuncture Derived from Animal
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Among the various treatment methods involving the use of natural substances, pharmacopuncture using animal venom is a relatively new form of acupuncture that has been developed in South Korea and is gaining popularity worldwide. Pharmacopuncture with animal venom is widely used in clinical practice; therefore, ensuring its procedural safety is crucial. This study aimed to evaluate the safety and toxicity of pharmacopuncture using animal venom. Methods: In October 2021, nine samples of animal venom-derived pharmacopuncture products were randomly collected from four External Herbal Dispensaries (EHDs). These samples underwent sterility and microbial limit testing to ensure they were free from microbial contamination. Toxicity tests were conducted using three different cell lines to evaluate cytotoxic effects. Results: The sterility and microbial limit tests showed no microbial growth in any of the pharmacopuncture samples. However, the toxicity tests revealed that bee venom exhibited strong cytotoxicity. Furthermore, samples containing Bovis Calculus, Fel Ursi, and Moschus also demonstrated varying degrees of cytotoxic effects. Conclusion: This study is the first to analyze the safety and toxicity of animal venomderived pharmacopuncture products, providing evidence for its procedural safety. Although the samples analyzed were limited to four EHDs, these findings highlight the importance of further research on the safety and toxicity of pharmacopuncture to ensure its clinical application is both effective and safe.
Abstract
Objectives: Among the various treatment methods involving the use of natural substances, pharmacopuncture using animal venom is a relatively new form of acupuncture that has been developed in South Korea and is gaining popularity worldwide. Pharmacopuncture with animal venom is widely used in clinical practice; therefore, ensuring its procedural safety is crucial. This study aimed to evaluate the safety and toxicity of pharmacopuncture using animal venom. Methods: In October 2021, nine samples of animal venom-derived pharmacopuncture products were randomly collected from four External Herbal Dispensaries (EHDs). These samples underwent sterility and microbial limit testing to ensure they were free from microbial contamination. Toxicity tests were conducted using three different cell lines to evaluate cytotoxic effects. Results: The sterility and microbial limit tests showed no microbial growth in any of the pharmacopuncture samples. However, the toxicity tests revealed that bee venom exhibited strong cytotoxicity. Furthermore, samples containing Bovis Calculus, Fel Ursi, and Moschus also demonstrated varying degrees of cytotoxic effects. Conclusion: This study is the first to analyze the safety and toxicity of animal venomderived pharmacopuncture products, providing evidence for its procedural safety. Although the samples analyzed were limited to four EHDs, these findings highlight the importance of further research on the safety and toxicity of pharmacopuncture to ensure its clinical application is both effective and safe.
참고문헌 (38)
- Atanasov AG, "Discovery and resupply of pharmacologically active plant-derived natural products : a review", Biotechnol Adv, 33(8), pp.1582~1614 (2015)
- Lee YJ, "Usage report of pharmacopuncture in musculoskeletal patients visiting Korean medicine hospitals and clinics in Korea", BMC Complement Altern Med, 16(1), pp.292~ (2016)
- Sung SH, "Current status of management on pharmacopuncture in Korea through introduction of an accreditation system", J Pharmacopuncture, 22(2), pp.75~82 (2019)
- Sung SH, "Animal venom for medical usage in pharmacopuncture in Korean medicine : current status and clinical implication", Toxins(Basel), 13(2), pp.105~ (2021)
- Utkin YN, "Animal venom studies : current benefits and future developments", World J Biol Chem, 6(2), pp.28~33 (2015)
- Hakim MA, "Centipede venoms and their components : resources for potential therapeutic applications", Toxins(Basel), 7(11), pp.4832~4851 (2015)
- Sung SH, "Bee venom acupuncture for neck pain : a review of the Korean literature", Toxins(Basel), 15(2), pp.129~ (2023)
- Abd El-Aziz TM, "Snake venoms in drug discovery : valuable therapeutic tools for life saving", Toxins(Basel), 11(10), pp.564~ (2019)
- Hwang SI, "Toxic animalbased medicinal materials can be effective in treating endometriosis : a scoping review", Toxins(Basel), 13(2), pp.145~ (2021)
- Kim H, "Potential therapeutic applications of bee venom on skin disease and its mechanisms : a literature review", Toxins(Basel), 11(7), pp.374~ (2019)
- Ryu JM, "Sweet bee venom triggers multiple cell death pathways or spurs acute cell rupture according to its concentration in THP-1 monocytic leukemia cells", Genes(Basel), 13(2), pp.223~ (2022)
- Kim SY, "Different clinical features of anaphylaxis according to cause and risk factors for severe reactions", Allergol Int, 67(1), pp.96~102 (2018)
- Park J, "Pharmacopuncture in Korea : a systematic review and meta-analysis of randomized controlled trials", Evid Based Complement Alternat Med, 2016, pp.4683121~ (2016)
- Ministry for Health, Welfare and Family Affairs, "Guideline on installation and utilization of external herbal dispensaries of traditional Korean medicine clinics and share-use of herbal dispen saries", Ministry for Health, Welfare and Family Affairs, 14~ (2009)
- Sung SH, "Current status and future perspective of external herbal dispensaries preparing traditional herbal medicine in South Korea : the first National-Wide Survey results", BMC Complement Med Ther, 20(1), pp.354~ (2020)
- "Establishment of the second accreditation criteria for external herbal dispensaries" (2022)[URL]
- "Accreditation criteria for external herbal dispensaries (‘20.12 standard)" (2020)[URL]
- "Revisions to the accreditation criteria for external herbal dispensaries" (2020)[URL]
- Sufian MA, "Quality control parameters of parenteral pharmaceuticals based on pharmacopoeias", IAJPS, 3(12), pp.1624~1638 (2016)
- "Annex 2: WHO good manufacturing practices for sterile pharmaceutical products" (2022)[URL]
- Park JS, "Live bee acupuncture(Bong-Chim)dermatitis : dermatitis due to live bee acupuncture therapy in Korea", Int J Dermatol, 52(12), pp.1519~1524 (2013)
- Sahiner UM, "Hymenoptera venom allergy : how does venom immunotherapy prevent anaphylaxis from bee and wasp stings?", Front Immunol, 10, pp.1959~ (2019)
- Kim K, "Characteristics of adverse events in bee venom therapy reported in South Korea : a survey study", Toxins(Basel), 14(1), pp.18~ (2021)
- Blank S, "Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2(Api m 1)produced in insect cells", Protein Pept Lett, 18(4), pp.415~422 (2011)
- Lee KH, "intravenous single dose toxicity of sweet bee venom in sprague-dawley rats", J Pharmacopuncture, 18(3), pp.49~56 (2015)
- Shapira A, "Toxin-based therapeutic approaches", Toxins(Basel), 2(11), pp.2519~2583 (2010)
- Kim HJ, "A review of bee venom acupuncture for articular diseases of single type joint in the Journal of Korean Medicine", J Korean Med Rehabi, 31(1), pp.119~135 (2021)
- Lee SW, "Experimental studies on the acute toxicity of Bos taurusㆍUrsus thibetanusㆍMoschus extrct solution(BUM)for herbal-acupuncture", J Pharmacopunct, 5(2), pp.6~24 (2002)
- Kong W, "Determination of multicomponent contents in Calculus bovis by ultra-performance liquid chromatography–evaporative light scattering detection and its application for quality control", J Sep Sci, 33(10), pp.1518~1527 (2010)
- Yu ZJ, "Calculus bovis : a review of the traditional usages, origin, chemistry, pharmacological activities and toxicology", J Ethnopharmacol, 254, pp.112649~ (2020)
- Brites D, "Bilirubin neurotoxicity : a narrative review on long lasting, insidious, and dangerous effects", Pediatr Med, 4, pp.34~ (2021)
- Huang F, "From dried bear bile to molecular investigation of differential effects of bile acids in ex vivo and in vitro models of myocardial dysfunction : relevance for neuroinflammation", Brain Behav Immun Health, 32, pp.100674~ (2023)
- Bahar R, "Update on new drugs and those in development for the treatment of primary biliary cholangitis", Gastroenterol Hepatol(N Y), 14(3), pp.154~163 (2018)
- Kotb MA, "Molecular mechanisms of ursodeoxycholic acid toxicity & side effects : ursodeoxycholic acid freezes regeneration &induces hibernation mode", Int J Mol Sci, 13(7), pp.8882~8914 (2012)
- Liu K, "Zoology, chemical composition, pharmacology, quality control and future perspective of Musk(Moschus) : a review", Chin Med, 16(1), pp.46~ (2021)
- Liu S, "Muscone induces CYP1A2and CYP3A4 enzyme expression in L02 human liver cells and CYP1A2 and CYP3A11 enzyme expression in Kunming mice", Pharmacology, 99(5-6), pp.205~215 (2017)
- Jang J, "Repeateddose toxicity testing of scolopendrid pharmacopuncture in Sprague-Dawley rats", J Acupunct Res, 37(2), pp.110~117 (2020)
- Park Y, "Toxicity and safety classification of 4 animal medicines-focusing on venoms from bee, snake, blister beetle and scolopendrid-", J Soc Prev Korean Med, 20(1), pp.125~144 (2016)